Construction of an anti-apoptosis CHO cell line for biopharmaceutical production.
- Author:
Da-Zhi LAI
1
;
Ling FU
;
Chang-Ming YU
;
Lian-Quan QI
;
Shao-Jie WENG
;
Ting YU
;
Hai-Tao WANG
;
Wei CHEN
Author Information
1. Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Apoptosis;
genetics;
physiology;
Biopharmaceutics;
CHO Cells;
cytology;
metabolism;
Cricetinae;
Cricetulus;
Glutamate-Ammonia Ligase;
genetics;
metabolism;
Interferon-beta;
metabolism;
Models, Genetic;
Proto-Oncogene Proteins c-bcl-2;
genetics;
metabolism
- From:
Chinese Journal of Biotechnology
2003;19(3):322-326
- CountryChina
- Language:Chinese
-
Abstract:
Mammalian cells are prone to apoptosis when cultured in large scale for production of biopharmaceuticals. And this will reduce production duration and result in high cost of production. Apoptosis is triggered by various factors, and delicately regulated by a set of genes. Bcl-2, a component integrated in mitochondria membrane, is an important member of these genes. By maintaining the integrity of mitochondria membrane, Bcl-2 keeps cytochrome C from releasing into cytoplasm, and thus blocks the activation of caspases, and subsequent onset of apoptosis. Over-expression of Bcl-2 has proven to be useful in blocking apoptosis in various cell lines, including CHO, hybridoma, myeloma, lymphoma and insect cells. Ammonia, a metabolite of cultured cells, however, showed apparent pro-apoptosis activity. In living cells, ammonia can be utilized by glutamine synthetase (GS) to synthesize glutamine, and thus lower the concentration of ammonia in medium, and its negative effects. Glutamine is essential to living cells. If not added into medium, glutamine can only be synthesized by GS, which makes GS a qualified selection marker. This marker can be used for gene amplification by adding into medium increased concentration of MSX, an inhibitor of GS. In this study, we over-expressed Bcl-2 using GS amplification in a recombinant CHO cell line stably expressing human interferon-beta. The modified cell line, with higher expression of Bcl-2 and lower production of ammonia, exhibited good anti-apoptosis quality and higher interferon-beta production in continuous culture.
